Q2 2025 · 13F-HR
TRV GP V, LLCholdings as filed
Filed 2025-08-08 · accession 0000950123-25-007373
$165.7M
Reported value
4
Positions
2025-06-30
Period end
The Brief · TRV GP V, LLC · Q2 2025
AI · grounded in 13F
TRV GP V, LLC established a new position in RAPP valued at $81.1M. The fund also initiated a position in SEPN for $65.7M. Additional new holdings include MAZE at $11.7M and CRGX at $7.2M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75383L102 | RAPP | RAPPORT THERAPEUTICS, INC. | $81.1M | 49.0% | 7,135,233 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA, INC. | $65.7M | 39.7% | 6,215,591 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS, INC. | $11.7M | 7.04% | 950,800 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS, INC. | $7.2M | 4.32% | 1,737,216 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.